Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Benzodiazepines: clinical pharmacology and therapeutic use.

× No keyword cloud information.

133 in total

1. N-desmethyldiazepam and amylobarbitone sodium as hypnotics in anxious patients. Plasma levels, clinical efficacy and residual effects.

Authors: M Tansella; O Siciliani; L Burti; M Schiavon; C Zimmermann; M Gerna; G Tognoni; P L Morselli
Journal: Psychopharmacologia Date: 1975

2. Residual effects and skills related to driving after a single oral administration of diazepam, medazepam or lorazepam.

Authors: K Seppälä; K Korttila; S Häkkinen; M Linnoila
Journal: Br J Clin Pharmacol Date: 1976-10 Impact factor: 4.335

3. Plasma concentrations of diazepam and of its metabolite N-desmethyldiazepam in relation to anxiolytic effect.

Authors: H H Dasberg; E van der Kleijn; J P Guelen; H M van Praag
Journal: Clin Pharmacol Ther Date: 1974-05 Impact factor: 6.875

4. Cross-national study of the extent of anti-anxiety-sedative drug use.

Authors: M B Balter; J Levine; D I Manheimer
Journal: N Engl J Med Date: 1974-04-04 Impact factor: 91.245

5. Concentration-effect relationships with major and minor tranquilizers.

Authors: S H Curry
Journal: Clin Pharmacol Ther Date: 1974-07 Impact factor: 6.875

6. The residual effects of flurazepam.

Authors: A J Bond; M H Lader
Journal: Psychopharmacologia Date: 1973-09-28

7. Withdrawal from benzodiazepine therapy.

Authors: L E Hollister
Journal: JAMA Date: 1977-04-04 Impact factor: 56.272

8. Benzodiazepines in depressive disorders.

Authors: A F Schatzberg; J O Cole
Journal: Arch Gen Psychiatry Date: 1978-11

9. Plasma concentrations of diazepam, noradiazepam and amylobarbitone after short-term treatment of anxious patients.

Authors: M Tansella; C Zimmermann Tansella; L Ferrario; L Preziati; G Tognoni; M Lader
Journal: Pharmakopsychiatr Neuropsychopharmakol Date: 1978-03

10. Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines.

Authors: A Kales; M B Scharf; J D Kales; C R Soldatos
Journal: JAMA Date: 1979-04-20 Impact factor: 56.272

37 in total

Review 1. Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines.

Authors: W A Colburn; M L Jack
Journal: Clin Pharmacokinet Date: 1987-09 Impact factor: 6.447

2. Single dose pharmacokinetics and pharmacodynamics of oral oxazepam in very elderly institutionalised subjects.

Authors: J Sonne; S Loft; M Døssing; S Boesgaard; F Andreasen
Journal: Br J Clin Pharmacol Date: 1991-06 Impact factor: 4.335

3. Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. I: Lorazepam.

Authors: S K Gupta; E H Ellinwood; A M Nikaido; D G Heatherly
Journal: J Pharmacokinet Biopharm Date: 1990-04

4. Frequency-dependent actions of benzodiazepines on GABAA receptors in cultured murine cerebellar granule cells.

Authors: J R Mellor; A D Randall
Journal: J Physiol Date: 1997-09-01 Impact factor: 5.182

5. Detection of benzodiazepine receptor occupancy in the human brain by positron emission tomography.

Authors: H Shinotoh; M Iyo; T Yamada; O Inoue; K Suzuki; T Itoh; H Fukuda; T Yamasaki; Y Tateno; K Hirayama
Journal: Psychopharmacology (Berl) Date: 1989 Impact factor: 4.530

6. Inhibition of diazepam metabolism in microsomal- and perfused liver preparations of the rat by desmethyldiazepam, N-methyloxazepam and oxazepam.

Authors: E M Savenije-Chapel; A Bast; J Noordhoek
Journal: Eur J Drug Metab Pharmacokinet Date: 1985 Jan-Mar Impact factor: 2.441

Benzodiazepines: clinical pharmacology and therapeutic use.